Clinical Trials

• Treatment of Bone Marrow Failure, Post Allogeneic Bone Marrow Transplant,w ith CD34+ Cell-Enriched Hematopoietic Stem Cell Infusion (Miltenyi Biotec's CliniMACS CD34 Reagent System) A HDE Treatment Protocol

  This study is not currently enrolling.

  Associated Conditions: Multiple Tumor Types

  Research Area: Clinical Cancer Research

  [Shell Only] - HUD/CUD.